parkin mutation analysis in clinic patients with early-onset Parkinson's disease
β Scribed by Poorkaj, P. ;Nutt, J. G. ;James, D. ;Gancher, S. ;Bird, T. D. ;Steinbart, E. ;Schellenberg, G. D. ;Payami, Haydeh
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 164 KB
- Volume
- 129A
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Parkin, an E2βdependent ubiquitin protein ligase, carries pathogenic mutations in patients with autosomal recessive juvenile parkinsonism, but its role in the lateβonset form of Parkinson's disease (PD) is not firmly established. Previously, we detected linkage of idiopathic PD to the r
We report the clinical, genetic, and neuropathological findings of a seven generation-spanning pedigree with 196 individuals, 25 of whom had levodopa-responsive parkinsonism. Genetic analyses indicated Parkin mutations in 77 subjects. Among the 25 patients, 5 carried compound heterozygous mutations
Hunter disease (mucopolysaccharidosis type I1 or MPS 11) is an X-linked recessive lysosomal storage disease resulting from a deficiency of L-iduronate 2-sulfate-sulfatase (IDS) (EC 3.1.6.13), which is involved in the catabolism of glycosaminoglycans (GAGS) . Excessive accumulation in the tissues and
genes and who were found to be negative. 1 In this group of 122 patients, we identified 5 patients with an FMR1 premutation and in 4 of them a definite diagnosis of fragile Xassociated tremor/ataxia syndrome (FXTAS) could be made, based on the proposed diagnostic criteria for FXTAS. We proposed base